PTEN and colorectal carcinoma: Patients experiencing reduced expression of mir-9 have poor clinical outcomes.9 MiR-17-5P reduces the survival of CRC patients by deactivating PTEN.54 Schetter et al have demonstrated that mir-21 overexpression is linked to poor clinical outcomes and low survival rate in colon adenocarcinoma patients.107